Information center / / / / /

Why racial diversity matters in breast cancer clinical trials

Black people are very underrepresented in clinical trials, especially cancer trials. Yet Black people in the United States have higher rates of several types of cancer. Photo: Pexels

(Carly Werner/ Healthline) — Clinical trials are key to learning about conditions like cancer and finding new treatments. These trials, which happen after years of research, are a chance to try out promising new therapies in people.

Current treatments for breast cancer were once tested in clinical trials.

Many women have benefited from being a part of a clinical trial. Lives have been improved, prolonged, and saved as a result of clinical trials.

But People of Color often face barriers in accessing healthcare. They also have lower rates of participation in clinical trials. (…)